Detailed View
ROIV - Roivant Sciences Ltd.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
24,491,157,504
Adj EBIT (TTM)
-515,068,000
Enterprise Value
20,964,366,504
Last Price
34.05
Earnings Yield
-2.46%
Return on Capital
-9.49%
Capital
5,427,443,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-K (Q4 derived) | 2026 | 2,520,000 | 415,240,000 |
| 2025-12-31 | 10-Q | 2026 | 1,999,000 | -339,153,000 |
| 2025-09-30 | 10-Q | 2026 | 1,571,000 | -306,233,000 |
| 2025-06-30 | 10-Q | 2026 | 2,170,000 | -284,922,000 |
| 2025-03-31 | 10-K (Q4 derived) | 2025 | -39,572,000 | -267,014,000 |
| 2024-12-31 | 10-Q | 2025 | 9,018,000 | -274,381,000 |
| 2024-09-30 | 10-Q | 2025 | 4,475,000 | -341,713,000 |
| 2024-06-30 | 10-Q | 2025 | 55,132,000 | -120,186,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.